The Safety of Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty
Phase of Trial: Phase IV
Latest Information Update: 02 Sep 2017
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Adverse reactions
- 08 Feb 2017 Status changed from recruiting to completed.
- 23 Mar 2016 Planned End Date changed from 1 Nov 2015 to 1 Dec 2016 as per ClinicalTrials.gov record.
- 23 Mar 2016 Planned primary completion date changed from 1 Nov 2015 to 1 Dec 2016 as per ClinicalTrials.gov record.